Clinical trial
Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum…
NCT00380393 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00380393 |
|---|---|
| Title | Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children. |
| Official title | A Study of the Efficacy Against Episodes of Clinical Malaria Due to P. Falciparum Infection of GSK Biologicals Candidate Vaccine RTS,S/AS01, Administered According to a 0,1,2-months Schedule in Children Aged 5 to 17 Months Living in Tanzania & Kenya |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | GSK malaria vaccine 257049 Vaccine, Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine |
| Enrollment | 894 |
| Start date | Jan 3, 2007 |
| Primary completion | Aug 15, 2008 |
| Completion | Nov 11, 2008 |
| First posted | Sep 26, 2006 |
| Last update posted | Jul 3, 2018 |
| Countries | Kenya, Tanzania |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: